SCLC patients treated with and without prophylactic cranial irradiation (PCI) in palliative setting after systemic treatment with checkpoint inhibitors (CPI) – Data from the Clinical Research platform Into molecular testing, treatment and outcome of (non-) Small cell lung carcinoma Patients (CRISP; AIO-TRK-0315) 10. November 2023 Reck M., Gauler T., Waller C.F., Fischer R., Christopoulos P., Bruch H.-R., Elender C., Ludwig P., Hipper A., Medinger T., Tech S., Binninger A., Jänicke M., Gleiber W., Hoknecht P., Sadjadian P., Griesinger F., Thomas M., Eberhardt W.E.E., Sebastian M. Oncol Res Treat. 2023;46 (suppl. 5)(V46):7 Link Multiple myeloma: Antiresorptive therapy in patients with osteolytic lesions and impaired renal function – data from the MYRIAM registry von der Heyde, Reiser, M., Nusch, A., Dechow, T., Jacobasch, L., Zingerle, M., Schweizer, C., Medinger, T., Jänicke, M., Potthoff, K., Engelhardt, M., Einsele, H.,… Weiterlesen 1L maintenance therapy in patients with newly diagnosed advanced or metastatic ovarian cancer in routine care in Germany: results from the German registry platform SMARAGD Juhasz-Böss I, Nusch A, Zaiss M, Fuchs R, Müller A, Jänicke M, u. a. Oncol Res Treat. 2023;46 (suppl 5)(V1005):152–3 Link… Weiterlesen